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ABSTRACT
Development of drug resistance limits the effectiveness of anticancer treatments.
Understanding the molecular mechanisms triggering this event in tumor cells may
lead to improved therapeutic strategies. Here we used RNA-seq to compare the
transcriptomes of a murine erythroleukemia cell line (MEL) and a derived cell line
with induced resistance to differentiation (MEL-R). RNA-seq analysis identified a total
of 596 genes (Benjamini–Hochberg adjusted p-value < 0.05) that were differentially
expressed bymore than two-fold, of which 81.5% (486/596) of genes were up-regulated
in MEL cells and 110 up-regulated in MEL-R cells. These observations revealed that for
some genes the relative expression of mRNA amount in the MEL cell line has decreased
as the cells acquired the resistant phenotype. Clustering analysis of a group of genes
showing the highest differential expression allowed identification of a sub-group among
genes up-regulated in MEL cells. These genes are related to the organization of the
actin cytoskeleton network. Moreover, the majority of these genes are preferentially
expressed in the hematopoietic lineage and at least three of them,Was (Wiskott Aldrich
syndrome),Btk (Bruton’s tyrosine kinase) andRac2, whenmutated in humans, give rise
to severe hematopoietic deficiencies. Among the group of genes that were up-regulated
in MEL-R cells, 16% of genes code for histone proteins, both canonical and variants.
A potential implication of these results on the blockade of differentiation in resistant
cells is discussed.
Subjects Molecular Biology, Hematology
Keywords RNA-seq, Cell differentiation, HMBA-resistant, Wiskott-Aldrich syndrome, Bruton’s
tyrosine kinase, Erytrhroleukemia cells
INTRODUCTION
Cancer cells are distinguished from their normal counterparts by several hallmarks,
including uncontrolled growth, lack of response to apoptotic signals and blockade
of differentiation (Hanahan &Weinberg, 2000; Hanahan &Weinberg, 2011). These
characteristics serve as a framework for testing different protocols aimed at eliminating
tumor cells by aggressive chemotherapy or radiotherapy. Alternatively, cancer cells may be
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forced to resume the process of maturation by differentiation agents, which generally
have less toxicity than conventional cancer treatments. An example of a successful
clinical application of differentiation therapy is all-trans-retinoic acid (ATRA) for
treatment of acute promyelocytic leukemia, which induces terminal differentiation of
promyelocytic leukemic cells (Nowak, Stewart & Koeffler, 2009). Other differentiation-
inducing agents, such as histone-deacetylase (HDAC) inhibitors (Lane & Chabner, 2009),
cytidine analogs (e.g., 5′-aza-2′-deoxycytidine) (Fenaux et al., 2010), and tyrosine kinase
inhibitors (e.g., imatinib) (Haouala et al., 2011) have been less successful in the treatment
of leukemias and solid tumor cancers. An obstacle to all cancer therapies is the acquisition
of drug resistance that develops in response to repeated therapies, which eventually leads
to relapse in most patients (Rebucci & Michiels, 2013).
In vitro differentiation models have proved to be extremely useful to study the molecular
events associated with the blockade of cell differentiation exhibited by some tumor cells
and the requirements for re-entry into the cell differentiation program. The mouse
erythroleukemia (MEL) model developed by Friend et al. (1971) is an outstanding example
that remains as a solid platform to evaluate tumor cell reprogramming after more than
40 years since its description.
Friend erythroblasts are derived from mice infected with the Friend complex virus.
Insertion of the Friend spleen focus-forming virus (SFFV) genome occurs several kilobases
upstream of the Sfpi1/PU.1 locus initiation start site (Fernández-Nestosa et al., 2008).
This causes the constitutive activation of Sfpi/PU.1 resulting in the blocking of erythroid
differentiation and the development of erythroleukemia (reviewed in Ruscetti, 1999). MEL
cells can be induced to reinitiate the differentiation program by the addition of chemical
agents such as hexamethylene bisacetamide (HMBA) (Fernández-Nestosa et al., 2008).
We have previously reported the establishment of an HMBA-resistant cell line (MEL-R)
before. These cells were obtained after months of MEL cell culture in the presence of
a differentiation inducer. The resulting cell line retained most of the native MEL cell
characteristics. Unexpectedly, we found that Sfpi1/PU.1 remains silent even thoughMEL-R
cells do not differentiate, and this silencing persists in the presence of chemical inducers
other than HMBA. Nevertheless, the SFFV integration site maps exactly to the same
location both in MEL and MEL-R cell lines (2,976 bp downstream of the URE distal
element). We also showed that inactivation of Sfpi1/PU.1 in the resistant MEL-R cell line
wasmediated byDNAmethylation at the promoter near to CpG islands (Fernández-Nestosa
et al., 2013). For all these reasons, we believe MEL-R cells might constitute a useful model
to study mechanisms that trigger inducer-resistant cell differentiation. Here we compared
the differential expression profiles of MEL and MEL-R cells using RNA-seq to identify
sequences potentially involved in the control of HMBA resistance. Our results revealed
that a higher proportion of differentially-expressed genes are up-regulated in MEL cells
than in MEL-R cells. Interestingly, a group of highly up-regulated sequences in MEL
cells corresponded to genes encoding actin cytoskeleton proteins. A proportion of genes
up-regulated in MEL-R cells belonged to histone coding genes. Canonical histone proteins
H1, H2A, H2B, H3 and H4, are replication-dependent and their expression is coordinated
with DNA replication, occurring primarily during the S phase of the cell cycle (Rattray &
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Muller, 2012). There are nonallelic variants mainly of the H1, H2A, H2B and H3 histones
that are not restricted in their expression to the S phase and have different physiological
roles. Both groups, however, are essential elements of the nucleosome architecture and
contribute to chromatin organization (Talbert & Henikoff, 2010). A potential contribution
of histone gene expression to the differentiation block is also discussed.
MATERIALS AND METHODS
Cell cultures and treatment
MEL-DS19 cell line (hereafter called MEL) was obtained from Arthur Skoultchi (Albert
Einstein College of Medicine, New York, USA). MEL-resistant cell line (hereafter called
MEL-R) derived from MEL-DS19 was previously established in our lab by growing MEL
cells continuously in the presence of 5 mM HMBA (Fernández-Nestosa et al., 2008). 3T3-
Swiss albino fibroblasts cells were obtained from the Animal Cell Culture Facility from the
Centro de Investigaciones Biológicas, CSIC. Cells were cultured in Dulbecco’s modified
Eagle’s medium containing 10% fetal bovine serum, 100 units/ml penicillin and 100 µg/ml
streptomycin (Gibco). Cell differentiationwas induced by exposing logarithmically growing
cell cultures to 5 mM HMBA. MEL-R cells were routinely cultured in the presence of 5
mM HMBA. Hemoglobinized cells were quantified by determining the proportion of
benzidine-staining positive cells (B+) in the culture.
RNA isolation and RNA-seq analysis
Total RNA was isolated from 1×107 cells using the RNeasy kit (Qiagen). DNase I was
used to degrade any possible DNA contamination. 1 µg of total RNA was used to prepare
standard RNA-seq libraries (TruSeq RNA Sample Preparation Kit, Illumina) based on
polyA+ isolation. RNA concentration ranged from 326 to 394 ng/µl, and samples showed
optimal integrity with RIN values of 9.80. The libraries had an average length of 337–367 nt
and were quantified by quantitative PCR (Kapa Biosystems) using a previously quantified
library as standard. Samples were loaded onto a lane of a flowcell using the Cluster Station
apparatus (Illumina) and sequenced on the Illumina GAIIx platform (Parque Científico de
Madrid, Spain) under a single read (1×75) protocol. There were approximately 25 million
and 17 million reads (75-nt length) for MEL and MEL-R libraries, respectively, which were
used for further bioinformatics analysis. The median quality score was >30 across all sites
of the reads (http://hannonlab.cshl.edu/fastx_toolkit/index.html). The sequencing reads
were mapped to the mouse reference genome (Mus_musculus_NCBI_build37.67.cdna,
30-04-2012) with TopHat v2.0.1. TopHat’s mapped reads were processed using the
program Cuffdiff, a part of the Cufflinks software suite v2.0.0 (Trapnell et al., 2012) and
measured as fragments per kb of exon per million fragments mapped (FPKM) (Trapnell et
al., 2012). The workflow outlining the analysis of RNA sequencing data is shown in Fig S1.
Samples (unreplicated MEL and MEL-R) were further analyzed using the DESeq package
for R Statistical Analysis (Anders & Huber, 2010). We used DESeq as a complementary
differential gene expression analysis to compare the results with those obtained by Cuffdiff
(Fig. S2). DESeq was employed as an additional DEG calling method since it performs a
different expression test (Fishers’ exact test) than Cuffdiff (t -test). A list of differentially
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expressed genes detectedwith bothmethodologies is included in Supplemental Information
(Cuffdiff/DESeq analysis).
Quantitative real-time PCR validation
Quantitative real-time-PCR (qRT-PCR) was used to validate the relative expression of
genes selected from the RNA-seq analysis. Total RNA was extracted from 1×107 MEL and
MEL-R cells as described above. In total, 2 µg of isolated RNA were transcribed to cDNA
using random hexamers and 200 U of SuperScriptII Reverse Transcriptase (Invitrogen).
Reactions were performed in triplicate using the SYBR Green Supermix (Bio-Rad) on an
iQ5 System (Bio-Rad). The conditions for the amplification were as follows: pre-denaturing
step of 95 ◦C for 3 min followed by 40 cycles of 9 ◦C for 30 s and 60 ◦C for 30 s, and a final
ramp step of 1 ◦C/10 sec from 60 ◦C to 94 ◦C. The primer sequences were designed with
Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/) (Untergasser et al., 2012) and are
listed in Table S1 (for actin cytoskeleton genes), Table S2 (for histone genes) and Table S3
(for methylases and demethylases). Relative gene expression was analyzed by the 2−11Ct
method as described in Schmittgen & Livak (2008).
Antibodies and western blotting
Control 3T3 fibroblast cells, MEL andMEL-R cells (2.5×106) were harvested, washed with
PBS and lysedwithNP-40 buffer (20mMTris–HCl pH7.5, 10%glycerol, 137mMNaCl, 1%
NP-40, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 2 mM EDTA) containing
protease inhibitors (all from Sigma). Protein lysates (10–30 µg) were separated by 12%
SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes (Bio-Rad).
The membranes were incubated with a mouse monoclonal anti-β-actin antibody (1:10,000,
Sigma) and a rabbit polyclonal anti-α-tubulin antibody (1:1,000, ABclonal) followed by
five washing steps with T-TBS (20 mM Tris–HCl, 150 mMNaCl, 0.1% Tween 20). Primary
antibodies were detected by incubating with HRP-conjugated anti-mouse (1:3,000, Santa
Cruz) or anti-rabbit IgG (1:1,000, DAKO) followed by five cycles of T-TBS washes. HP1 α
(1:1,000, Millipore) and Sam68 (1:1,000, Santa Cruz) antibodies were used for Fig. S3.
Bisulfite sequencing
The methylation analysis of Btk, Plek and Was promoter regions in MEL, MEL-R and
differentiated MEL cells was performed using sodium bisulfite conversion. Genomic
DNA from 8 ×104 cells was bisulfite-modified using the EZ DNA Methylation-Direct Kit
(Zymo Research). Four microlitres of treated DNA was amplified by PCR using primers
specific to the bisulfite-converted DNA for each promoter region with ZymoTaq DNA
Polymerase (Zymo Research). The conditions for the PCR were as follows: pre-denaturing
step of 95 ◦C for 10min, followed by 40 cycles of 95 ◦C for 30 s, 55–60 ◦C for 40 sec and 72 ◦C
for 40 s, with a final extension at 72 ◦C for 7min. The primer sequences were designed using
MethPrimer software (http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi) (Li
& Dahiya, 2002). The primers are listed in Table S4. PCR products were resolved in 1%
agarose gels followed by sequencing for methylation analysis, which was performed by
Secugen SL (CIB, Madrid).
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Cell cycle analysis
Cells (2× 105–1× 106) were harvested and fixed in 70% ethanol at 4 ◦C for 30 min.
Fixed cells were washed twice in PBS and stained with propidium iodide/RNAse solution
(Immunostep) for 15 min at room temperature (∼22 degrees Celsius). Cell cycle analysis
was performed on a Coulter EPICS XL (Beckman) flow cytometer and cell cycle profiles
were plotted using FlowJo software (Tree Star, Inc.) All samples were analyzed at least in
triplicates for each experiment.
Immunocytochemistry and confocal microscopy
Cells were plated on poly-L-lysine coated slides and incubated at 37 ◦C for 30 min. Cells
were fixed with 4% paraformaldehyde for 30 min, permeabilized with 0.1% Triton-X 100
in PBS for 30 min and blocked with 1% bovine serum albumin in PBS/0.1% Triton-X 100
for 1 h, all at RT. Cells were stained with anti-β-actin (Sigma) or anti-HP1α (Millipore)
antibodies, for 1 h at RT followed by washing twice with PBS. The primary antibody was
detected with an Alexa Fluor 568 secondary antibody (Molecular Probes) and 1 µg/ml
DAPI to stain nuclei, for 1 h at RT followed by two washes with PBS. Finally, cells were
mounted on a cover slip with Prolong Diamond Antifade Mountant reagent (Invitrogen).
Fluorescence images were acquired on a Leica TCS SP2 confocal microscope using a 100
× objective with zoom.
RESULTS
Differential gene expression between MEL and MEL-R
A total number of 25,791 genes were identified and deposited at the GEO database
(GSE83567). 596 genes (Benjamini–Hochberg adjusted p-value < 0.05) were differentially
expressed by more than two-fold between MEL and MEL-R cells, of which 486 genes were
up-regulated in MEL cells and 110 were up-regulated in MEL-R cells. We focused our
attention on sequences that were highly differentially expressed in MEL relative to MEL-R
cells. Figure 1A illustrates the heat map that includes all the genes, clustered based on
Ward’s analysis of minimum variance criterion (Ward Jr, 1963), with fold change of 2 or
more using Cuffdiff. An expanded heat map of genes showing highest fold-change values
is shown in Fig. 1B. Sfpi1/PU.1 was one of the selected genes that, as we demonstrated
previously (Fernández-Nestosa et al., 2008), is not expressed in the resistant cell line and
served in this case as a positive control for the RNA-seq efficiency. We observed that the
majority of the differentially expressed genes are up-regulated in MEL compare to MEL-R
cells (Fig. 1A and Fig S2).
Searching for common features among the cohort of highly expressed genes in MEL
cells, we found that several of these genes were implicated in the regulation of the actin
cytoskeleton organization. Table 1 lists the groups of these genes with the highest expression
difference between MEL and MEL-R cell lines. In addition to their relationship with the
actin pathway, eight of these genes (Btk, Dock2, Itgb2, Nckap1l, Plek, Rac2, Was and
Wdfy4) were preferentially expressed in hematopoietic cells (www.proteinatlas.org) and
at least three of them, Was (Wiskott Aldrich syndrome), Btk (Bruton’s tyrosine kinase)
and Rac2, when mutated in humans, give rise to severe deficiencies (Ambruso et al., 2000;
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Figure 1 Differentially expressed genes betweenMEL andMEL-R cell lines. (A) Analysis of differen-
tially expressed genes between MEL and MEL-R cell lines classified based on analysis of minimum vari-
ance (Ward Jr, 1963). (B) Heat map zoomed to amplify the genes with higher fold-change values. Genes
related to the actin cytoskeletal network are indicated by red asterisks. As expected, Sfpi/PU.1 presented
strong differences in expression towards the progenitor cells and served as control for RNA-seq efficiency
(green asterisk). (C) Heat map limited to histone gene expression. The color scales shown in all maps illus-
trate the log10 FPKM. Red and blue colors represent high and low expression, respectively.
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Table 1 List of differentially expressed genes related to actin cytoskeleton.
Gene Locus FPKM_MEL FPKM_MELR Log2 (Fold Change)b FDR-adjusted p-value
aPlek 11:16871208–16908721 90.85 0.06 10.56 0
aRac2 15:78389598–78403213 91.00 0.09 9.93 0
aDock2 11:34126863–34414545 23.21 0.03 9.74 1.08× 10−10
aBtk X:131076879–131117679 149.00 0.36 8.70 0
Itgb2 10:76993092–77028419 27.24 0.07 8.61 0
aNckap1l 15:103284255–103329231 13.91 0.05 7.98 0
aWas X:7658591–7667617 65.48 0 6.03 1.08×10−6
Wdfy4 14:33772732–33998252 9.78 0 3.29 5.65×10−6
Fgd3 13:49358478–49404577 6.88 0 2.78 7.64×10−4
aArhgef10l 4:140070399–140221820 6.28 0 2.65 2.65×10−3
Thy1 9:43851466–43856662 5.55 0 2.47 1.14×10−2
Notes.
aGenes validated by RT-qPCR.
bIn order to avoid in the log2FC calculation an infinite magnitude leading to indeterminate numerical results, the log2 (1) is taken when the FPKM value is 0.
Bosticardo et al., 2009; Conley et al., 2009). The majority of these genes were mostly linked
to the lymphoid or myeloid lineages, and several were reported in an erythroid context
(Schmidt et al., 2004).
Among the 110 selected genes whose expression was higher in MEL-R cells than in the
progenitor cell line, 16% encode histone proteins, mostly canonical but also variant histone
types. An expanded heat map illustrating the differential gene expression of histones in
MEL-R vs MEL cell lines is shown in Fig. 1C. The RNA-seq data revealed differences in the
expression of histones that belong to canonical H1, H2A, H2B and H3 groups, and to the
variant histones H1f0, H2afx and H3f3b. To understand the significance of the unexpected
up-regulation of histone gene expression in MEL-R cells, we compared their DNA content
with that of undifferentiated and HMBA-differentiated MEL cells by flow cytometry (Fig.
2). We found that the pattern of the major cell cycle phases, G1 vs S vs G2/M, was similar
between MEL-R cells and undifferentiated MEL progenitors (MEL-0 h). By contrast,
differentiated MEL cells (MEL-96 h) accumulated at G1, a phenomenon that has been
previously observed during MEL cell differentiation (Kiyokawa et al., 1993; Vanegas et al.,
2003; Fernández-Nestosa et al., 2008). Nevertheless, we observed that in terms of DNA
content, MEL-R cells acquired a tetraploid phenotype as revealed by the shift in DNA
content to the right (Fig. 2C).
Validation of differentially expressed genes by qRT-PCR
To validate the results obtained by RNA-seq, we measured the expression fold changes of
seven selected genes by qRT-PCR. Those genes (marked with ‘‘a’’ in Table 1), were selected
as they showed highest differential expression values, were related to the actin cytoskeletal
network and had hematopoietic specificity. RNA fromMEL cells treated with 5mMHMBA
were included to allow comparison between the undifferentiated and differentiated MEL
cells against the resistant MEL-R line. The expression patterns observed in all cases were
consistent with the RNA-seq results (Fig. 3), confirming the near absence of expression of
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Figure 2 Tetraploidy characterizes HMBA-resistant cells.DNA content (2C, 4C and 8C) assayed by
propidium iodide (PI) staining and flow cytometry show that (B) HMBA induced differentiated MEL cells
(MEL-96 h) accumulate in G1 as compared with the (A) uninduced cell line (MEL-0 h). (C) DNA pro-
file of HMBA-resistant cells (MEL-R) is similar to that observed in uninduced MEL cells regarding the
fractions of cells in G1, S and G2-M. However, the DNA content profile is shifted to the right of the panel
confirming that those cells become tetraploid.
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Figure 3 Validation of differentially regulated genes associated with the actin cytoskeletal network
by qRT-PCR. Selected genes that exhibited the highest FPKM values between MEL and MEL-R cell lines
by RNA-seq were chosen for further validation by qRT-PCR. For the progenitor cell line, samples treated
with HMBA for 96 h were also included. Data were normalized to β-actin expression for each sample.
Bars represent±SD of triplicate determinations (P < 0.05).
those genes in MEL-R cells. Significant differences were detected, however, when MEL-R
cells were compared withMEL cells induced to differentiate with HMBA. Some of the genes
such asWas, Rac2, Dock2 or Btk shared a similar expression profile to that obtained in the
resistant cell line, showing a tendency toward minimal expression, whereas the expression
levels of Plek, Arhgef10l or Nckap1l exhibited either no change or a higher expression than
that observed in differentiated cells.
Validation by qRT-PCR was also performed for histone genes and as before, we included
a comparison with HMBA-differentiated MEL cells. The results of the qRT-PCR analysis
were in agreement with those of the RNA-seq; in all cases, histone gene expression was
higher in MEL-R cells than in MEL cells (Fig. 4A). The difference in the level of expression
varied from more than ten-fold (Hist1h2bk) to two-fold (Hist1h2bn), except for Hist1h2bj
with values close to 1. The same patternwas observed between the differentiated (MEL-96 h)
and undifferentiated samples (Fig. 4B). These results ruled out the hypothesis that MEL-R
tetraploidy was responsible for histone gene over-expression.
Methylation status of CpG island promoters of Was, Btk and Plek
We have previously demonstrated that Sfpi1/PU.1 silencing in MEL-R cells is caused
by methylation of nearby CpG islands at its promoter (Fernández-Nestosa et al., 2013).
Moreover, reactivation of silenced Sfpi1/PU.1 occurs after treatment with 5-aza-2′-
deoxycytidine, a potent inhibitor of DNA methylation. To investigate whether DNA
methylation is responsible for the down-regulation in gene expression, we examined the
methylation status of Btk, Was and Plek promoters in undifferentiated and differentiated
MEL cells and in MEL-R cells by bisulfite sequencing. We mapped seven CpG islands
upstream of the transcriptional start site of Btk and Was (Figs. 5A and 5B) and five in
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Figure 4 Differential histone gene expression between progenitor and resistant cell lines and after dif-
ferentiation. qRT-PCR analysis of histone genes, canonical and variant, up-regulated in (A) MEL-R cells
relative to MEL cells, and (B) in HMBA-induced MEL cells (MEL 96 h) relative to uninduced cells (MEL).
Data were normalized to β-actin expression for each sample. Bars represent±SD of triplicate determina-
tions (P < 0.05).
the case of Plek (Fig. 5C). Bisulphite sequencing revealed that all the CpG sites were
hypomethylated in undifferentiated (0 h) and differentiated (96 h) MEL cells, whereas the
promoters remained hypermethylated at all CpG sites in the resistant cell line. Sites 3, 4
and 5 at the Btk promoter were within a highly cytosine-rich region that were converted to
thymine after bisulfite treatment, becoming difficult to resolve. We concluded from these
experiments that Btk, Was and Plek expression was silenced by promoter methylation in
MEL-R cell lines.
To confirm these results, we examined the expression pattern of the enzymes that
catalyze DNA methylation (Dnmt1, Dnmt3a and Dnmt3b) and those that are involved in
demethylation processes (Tet1, Tet2 and Tet3). Quantitative RT-PCR analysis revealed
that the level of expression of Dnmt1, the maintenance methylase enzyme, was higher in
MEL-R cells than in undifferentiated or differentiated MEL cells, whereas the smallest
changes were detected for the de novo methylases Dnmt3a and Dnmt3b between the
different cell populations (Figs. 6A–6C). By contrast, expression of Tet3, but not Tet1 and
Tet2 (enzymes involved in methyl group removal), was markedly reduced in MEL-R cells
(Figs. 6D–6F). These results showed that the increase in DNA methylation by Dnmt1 in
MEL-R cells overlaps with a decrease in demethylation by Tet3, which presumably results
in the silencing of Btk,Was and Plek promoters.
Actin cytoskeleton is poorly organized in resistant erythroleukemia
cells
The actin cytoskeleton is composed of an extensive variety of actin regulators and nucleators
that interact through a complicated protein network (Moulding et al., 2013; Bezanilla et
al., 2015). Our analysis indicated that the expression of a group of genes related to actin
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Figure 5 Methylation status of the Btk, Was and Plek promoters at the HMBA-resistant cells.Genomic
maps including exons (blue rectangles) and 5′ and 3′ UTRs (red rectangles) of (A) Btk, (B) Was and (C)
Plek. Expanded regions illustrate the promoter regions containing seven CpG islands (CG) for Btk and
Was and five CpG islands for Plek. ‘‘Lollipop’’ schematic diagram of methylation patterns is represented
below each sequence. Results from untreated (0 h) or HMBA-treated MEL cells (96 h) as well as MEL-R
cells are shown. Black and white lollipops indicate methylated or unmethylated CpGs, respectively, while
undetermined methylation status (see text for details) is represented in yellow.
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Figure 6 High and low expression of Dnmt1 and Tet3, respectively, are related to gene silencing and
DNAmethylation inMEL-R cells. qRT-PCR was performed for Dnmt1, Dnmt3a and Dnmt3bmethylases
and Tet1, Tet2 and Tet3 demethylases in undifferentiated, HMBA-treated MEL cells and in MEL-R cells.
Data were normalized to β-actin expression for each sample. Bars represent±SD of triplicate determina-
tions (P < 0.05).
3T3     MEL MEL-R
β-Actin
α-Tubulin
Figure 7 Actin protein is equally abundant in progenitor and resistant MEL cells.Western blot anal-
ysis for actin protein expression in MEL and MEL-R leukemia cells and in 3T3 control fibroblasts. Equal
amounts of protein were loaded and immunoblotted with an anti-β-actin antibody. Anti-α-tubulin was
used as a loading control.
cytoskeleton organization was depressed in the resistant erythroleukemia cell line. To
examine whether actin was affected by the silencing of genes related to actin polymerization
and/or regulation, we evaluated its protein expression by Western blotting and found that
its levels were similar between MEL and MEL-R cells (Fig. 7).
While these results demonstrate that the total amount of actin is equivalent for both cell
lines, it does not reveal details of the actin organization. We therefore used fluorescence
immunocytochemistry and confocal microscopy with anti-actin antibody to localize the
protein in fixed MEL and MEL-R cells. In both populations, a rim of actin fluorescence
was observed surrounding the nuclei (Fig. 8). However, MEL-R cells showed a significant
reduction of signal intensity. These results were consistent with the RNA-seq analysis,
Fernández-Calleja et al. (2017), PeerJ, DOI 10.7717/peerj.3432 12/20
MEL
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DAPI MergeActin
Figure 8 Actin cytoskeleton integrity is perturbed inMEL-resistant cell lines. Confocal immunofluo-
rescence microscopy of progenitor MEL cells and resistant MEL-R cells stained with a mouse monoclonal
anti-β-actin antibody (red). Nuclear DNA was stained with DAPI (blue). Scale bar is 10 µm.
where a marked reduction in the expression of actin-regulators genes was detected in
MEL-R cells, suggesting that actin cytoskeleton organization is perturbed in the resistant
erythroleukemia cell line.
DISCUSSION
Actin-regulatory proteins are preferentially expressed in murine
erythroleukemia cells
Cancer cells can acquire resistance to most traditional chemotherapy regimes and also
targeted therapies, and such an occurrence remains a great concern in cancer treatment
(Raguz & Yague, 2008; Rebucci & Michiels, 2013). Research on molecular and cellular
mechanisms that confer resistance to tumor cells is therefore a major focus of basic and
clinical investigation. Along this line, cell culture models have been crucial to advancing
the understanding of cancer cell resistance. We took advantage of an HMBA-resistant
cell line derived from murine erythroleukemia cells, previously established in our lab
(Fernández-Nestosa et al., 2008; Fernández-Nestosa et al., 2013), to study the molecular
events that contribute to the resistant phenotype. Both MEL and MEL-R cell lines are
blocked at the proerythroblast stage of differentiation but unlike the progenitor cell line,
MEL-R cells do not react to HMBA or other chemical inducers (e.g., DMSO, hemin and
butyrate) and remain resistant against cell differentiation. In the present study, we used
RNA-seq technology to identify genes potentially involved in the resistance mechanism.
Our analysis identified 596 genes that were differentially expressed between progenitor and
resistant cells, with the majority corresponding to genes up-regulated in MEL cells while
only 110 were up-regulated in MEL-R cells.
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Among these identified genes, some of them were prominent by their high expression
in MEL compared to MEL-R and for sharing two important features: belonging to the
actin regulatory network and being preferentially expressed in the hematopoietic lineage.
Also, at least three genes, Was, Btk and Rac2, when mutated are linked to severe human
hematological pathologies (Ambruso et al., 2000; Bosticardo et al., 2009; Conley et al., 2009).
Additionally, a recent study showed that biallelic mutations in the Dock2 gene result in
severe immunodeficiency that leads to defects in actin polymerization (Dobbs et al., 2015).
We hypothesized that proteins of the actin network such as Btk,Was and Plek among others
described in Table 1, are essential for such organization although it is unclear whether the
absence of expression is a cause or consequence of the defect.
Transcriptional down-regulation of Was, Btk and Plek correlate with
DNA promoter methylation
The network of actin filaments provides mechanical support to the cell cytoskeleton,
but it is increasingly acknowledged that it also contributes to other critical cellular
processes. Emerging evidence points to a role for the actin cytoskeleton in controlling
and regulating receptor signaling (Mattila, Batista & Treanor, 2016). We show here a
dramatic down-regulation of some of these network components in MEL-R cells, which
show a relationship with the methylation status at nearby CpG islands in the promoters
of Was, Btk and Plek. Over-expression of the methyltransferase Dnmt1, a maintenance
methylase that acts on hemimethylated DNA, and the repression of the demethylase Tet3,
supported these findings. These observations led us to speculate that silencing of most of
the cytoskeleton-associated proteins is linked to a hypermethylation status. Interestingly,
whereas no significant changes in total actin protein levels were observed betweenMEL and
MEL-R cells, weaker signals were detected in MEL-R cells by immunocytochemistry. This
observation might indicate poor actin organization. Regulation of actin polymerization
in eukaryotes requires a large number of accessory proteins. These proteins facilitate
polymerization or disassembly of monomeric globular actin (G-actin) into filamentous
actin (F-actin) and vice versa. Many of these proteins interact with each other. For
example, Btk interacts with Was and activates the protein by inducing its phosphorylation
in B cells (Sharma, Orlowski & Song, 2009). Btk also promotes a Rac2 response, leading to
F-actin rearrangements in mast cells (Kuehn et al., 2010). Dock2 is essential for lymphocyte
migration and mediates cytoskeletal reorganization through Rac2 activation (Fukui et
al., 2001). The transcription factor PU.1, responsible for the differentiation block in
MEL cells but silenced in MEL-R cells, is a major regulator of Btk expression both in
myeloid and lymphoid cells (Himmelmann et al., 1996; Christie et al., 2015). In summary,
the actin cytoskeleton network is orchestrated by multiple associated proteins with
possible overlapping roles, which contribute to different cell functions through complex
associations. As we showed here, silencing of some of these proteins has deleterious effects
on actin organization and we speculate that this might be a cause for the blockade of
differentiation in resistant cells.
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Increased expression of histone-coding genes characterizes MEL-R
cells transcriptome
As stated earlier, only 110 from 596 differentially-expressed genes were up-regulated
in MEL-R cells. This indicates a tendency towards a general decline of gene expression
in resistant cells, a situation comparable with what occurs during cell differentiation.
Silenced compartments composed mainly of heterochromatin are considered hallmarks
of the differentiated cells, a condition that progresses all through terminal differentiation
(reviewed in Politz, Scalzo & Groudine, 2013). A gradual increase in heterochromatinization
has been described in differentiating leukemia cells, as measured by the amount of
the heterochromatin-associated HP1 α, which increases continuously during MEL
differentiation (Estefania et al., 2012). Heterochromatinization is enhanced in MEL-R
cells relative to undifferentiated MEL cells, but is nevertheless lower than in HMBA-
differentiated cells (Fig. S3). The progressive gene silencing observed in MEL-R cells
is one additional element that suggests that these cells are at a midway point between
the undifferentiated and differentiated phenotypes due to a block somewhere in the
process. Concomitant with this gene silencing, histone genes emerge as the major group
up-regulated in the resistant phenotype. Initially, we associated the histone gene expression
pattern with the tetraploid status of the MEL-R cell lines. Polyploidy has been reported
in tumor cells as a result of stress-induced endoreplication (Storchova & Pellman, 2004;
Lee, Davidson & Duronio, 2009). Chronic HMBA treatment might represent a hard-hitting
stress that MEL-R cells overcome via a survival phenotype, i.e., tetraploidization, increased
cell size and impaired cell differentiation. Coward & Harding (2014) in a comprehensive
perspective support the hypothesis that tetraploidy provides numerous advantages during
tumor initiation. Moreover, they present data supporting that polyploidy facilitates
the acquisition of therapy-resistance in multiple cancers. MEL-R tetraploidy may
possibly involve chromatin rearrangements and consequently histone gene expression
changes. Nevertheless, the same fluctuations in histone gene expression were observed
in differentiated cells, indicating that differentiated and resistant cells share a common
mechanism not related to tetraploidy. In vivo, the quantity of reticulocytes, at a stage
comparable to the last stages of HMBA-induced differentiation, increases several fold in a
very short time (Ji, Jayapal & Lodish, 2008). It is speculated that a large number of histones
needs to be generated. When reticulocytes mature, before enucleation, major histones
are released into the cytoplasm through an unexpected nuclear opening that arises during
terminal erythropoiesis. This migration is crucial for chromatin condensation and terminal
differentiation (Zhao et al., 2016). We speculate that as an increase in histones occur both
in HMBA-differentiated MEL and in MEL-R cells, a failure in chromatin condensation,
either by an impairment in histone release or by a yet unknownmechanism, might interfere
with terminal cell differentiation in resistant cells.
CONCLUSIONS
A genome-wide RNA-seq analysis revealed that a subset of genes had significantly lower
levels of expression in MEL-R cells compared to MEL cells. Among the differentially
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expressed genes, a group up-regulated in the MEL cell line correspond to proteins related
to the actin cytoskeleton organization. We showed here that the expression of these genes,
i.e.,Was (Wiskott-Aldrich syndrome), Btk (Bruton’s tyrosine kinase) or Plek (Pleckstrin),
among others, is very low in the resistant phenotype MEL-R. Immunocytochemistry and
confocal microscopy analysis demonstrated an abnormal actin pattern in MEL-R cells,
but the total amount of actin protein is equivalent for both, MEL-R and MEL. These
results suggest that silencing of actin-related proteins influence the organization of the
cytoskeleton. Among the group of genes that were up-regulated in MEL-R cells, histone
proteins, both canonical and variants, were relevant.
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